Paxman: Regulatory clearance for CIPN in the EU and UK - Redeye

Redeye is positive about Paxman’s regulatory clearance in the EU and UK for its CIPN device. We view this as a significant milestone, transforming Paxman from a single-product company into a two-product company and reducing concentration risk. The company will soon initiate a pilot launch in the UK, with further updates about a broader launch expected during the remainder of 2026.

Länk till analysen i sin helhet: https://www.redeye.se/research/1174286/paxman-regulatory-clearance-for-cipn-in-the-eu-and-uk?utm_source=finwire&utm_medium=RSS